Nicotine restores monoamine neurotransmitter changes in the cortex and hippocampus of reserpinized rats as a model of depression

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 8, 2011, Pages 863-870

  Khadrawy, Yasser A ^a   El Shamy, K A I ^a   Mohamed, S I ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Cortex; Depression; Hippocampus; Monoamines; Nicotine; Reserpine

Indexed keywords

DOPAMINE; NICOTINE TARTRATE; NORADRENALIN; RESERPINE; SEROTONIN; SODIUM CHLORIDE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIDEPRESSANT AGENT; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; HIPPOCAMPUS; MALE; NONHUMAN; NORADRENALIN BRAIN LEVEL; RAT; SEROTONIN BRAIN LEVEL; SPECTROFLUOROMETRY; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CEREBRAL CORTEX; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; HIPPOCAMPUS; MALE; NEUROTRANSMITTER AGENTS; NICOTINE; NOREPINEPHRINE; RATS; RESERPINE; SEROTONIN;

EID: 80052369719     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. PICCIOTTO MR, CALDARONE BJ, KING SL ZACHARIOU V. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 2000; 22: 451-465.
2. QUATTROCKI E, BAIRD A, YURGELUN-TODD D. Biological aspects of the link between smoking and depression. Biol Psichiatry 2000; 8: 99-110.
3. MARKOU A, KOSTEN TR, KOOB GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998; 18: 135-174.
4. SAUN-PASCUAL RJ, ROSAS M, JIMENEZ-GENCHI A, RIVERAMEZA BL, DELGADO-PARRA, V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996; 57: 387-389.
5. HARO R, DRUCKER-COLIN R. Effects of long-term administration of nicotine and fluoxetine on sleep in depressed patients. Arch Med Res 2004; 35: 499-506.
6. MORENO-COUTINO A, CALDERON-EZQUERRO C, DRUCKER-COLIN R. Long-term changes in sleep and depressive symptoms of smokers in abstinence. Nicotine Tob Res 2007; 9: 389-396.
7. TIZABI Y, REZVANI AH, RUSSELL LT, TYLER KY, OVERSTREET D. Depressive characteristics of FSL rats: involvement of central nicotinic receptors. Pharmacol Biochem Behav 2000; 66: 73-77.
8. OVERSTREET DH, FRIEDMAN EF, MATHE AM, YADID G. The Flinders Sensitive Line rat: A selectivity bred putative animal model of depression. Neurosci Biobehav Rev 2005; 29: 739-759.
9. TIZABI Y, OVERSTREET DH, REZVANI AH, LOUIS VA, CLARK JR E, JANOWSKY DS, KLING MA. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 1999; 142: 193-199.
10. ANAND A, CHARNEY DS. Norepinephrine dysfunction in depression. J Clin Psychiatry 2000; 61: Suppl 10, 16-24.
11. RESSLER KJ, NEMEROFF CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12: Suppl 1, 2-19.
12. PACKARD MG, CAHILL L, MCGAUGH JL. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proc Nati Acad Sci USA 1994; 18: 8477-8481.
13. STEINVORTH S, LEVINE B, CORKIN S. Medial temporal lobe structures are needed to re-experience remote autobiographical memories: evidence from HM and WR. Neuropsychologia 2005; 43: 479-496.
14. DUMAN RS, CHARNEY DS. Cell atrophy and loss in major depression. Biol Psychiatry 1999; 45: 1083-1084
15. MACQUEEN GM, CAMPBELL S, MCEWEN BS, MACDONALD K, AMANO S, JOFFE RT, NAHMIAS C, YOUNG LT. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003; 100: 1387-1392.
16. ERIKSSON E. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin. Acta Psychiatry Scand 2000; 101: Suppl 402, 12-17.
17. GOODWIN FK, BUNNEY WE Jr. Depressions following reserpine: A reevaluation. Semin Psychiatry 1971; 3: 435-448.
18. PONZIO F, ACHILLI G, CALDERINI G, FERRETTI P, PEREGO C, TOFFANO G, ALGERI A. Depletion and recovery of neuronal monoamine storage in rats of different ages treated with reserpine. Neurobiol Aging 1984; 5: 101-104.
19. BOURIN M. Is it possible to predict the activity of a new antidepressive agent in animals with simple psychopharmacological test? Fundam Clin Pharmacol 1990; 4: 49-64.
20. NAKAGAWA T, UKAI K, OHYAMA T, GOMITA Y, OKAMURA H. Effect of dopaminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats. Pharmacol Biochem Behav 1997; 58: 829-836.
21. BARNETT A, TABER RI. ANTIDEPRESSANT AGENTS. IN: TURNER RA., HEBBORN P, eds. Screening Methods in Pharmacology. Academic Press New York 1971; 209-226.
22. JANCSAR S, LEONARD BE. Behavioral and neurochemical interactions between chronic reserpine and chronic antidepressants: a possible model for the detection of atypical antidepressants. Biochem Pharmacol 1983; 32: 1569-1571.
23. IRITANI S, TOHGI M, ARAI T, IKEDA K. Immunohistochemical study of the serotonergic neuronal system in an animal model of the mood disorder. Exp Neurol 2006; 201: 60-65.
24. CIARLONE AE. Further modification of a fluorometric method for analyzing brain amines. Microchem J 1978; 23: 9-12.
25. SEMBA J, MATAKI C, YAMADA SET, NANKAI M, TORU M. Antidepressant-like effects of chronic nicotine on learned helplessness paradigms in rats. Biol Psychiatry 1998; 43: 389-391.
26. TIZABI Y, GETACHEW B, REZVANI AH, HAUSER SR, OVERSTREET DH. Antidepressant-like effect of nicotine and reduced nicotinic receptor binding in Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. Prog Neuropsycopharmacol Biol Psychiatry 2009; 33: 398-402.
27. SCHECHTER LE, RING RH, BAYER CE, HAGHES ZA, KHAWAJA X, MALBERG JE, ROSENZWEIG-LIPSON S. Innovative approaches for the development of antidepressant drugs: Current and future strategies. J Am Soc Exp Neurotherap 2005; 2: 590-611.
28. BRADLEY PB. Introduction to Neuropharmacology. Wright Publishing Company, London, 1989.
29. O'LEARY OF, BECHTHOLT AJ, CROWLEY JJ, HILL TE, PAGE ME, LUCKI I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 2007; 192: 357-371.
30. FINN PD, CUNNINGHAM MJ, RICHARD DG, CLIFTON DK, STEINER RA. Serotonergic neurons are targets for leptin in the monkey. J Clin Endocr Metab 2001; 86: 422-426.
31. NEMEROFF CB. Recent advances in the neurobiology of depression. Psychopharmacol Bull 2002; 36: Suppl 2, 6-23.
32. FOOTE S, BLOOM FE, ASTON-JONES G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 1983; 63: 844-914.
33. MARKS MJ, PAULY JR, GROSS SD, DENERIS ES, HERMANS-BORGMEYER I, HEINEMAN SF, COLLINS AC. Nicotine binding and nicotinic receptors subunit RNA after chronic nicotine treatment. J Neurosci 1992; 12: 2765-2784.
34. AZNAR S, KOSTOVA V, CHRISTIANSEN SH, KNUDSEN GM. Alpha 7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum. Synapse 2005; 55: 196-200.
35. COMMONS KG. Alpha 4 containing nicotinic receptors are positioned to mediate postsynaptic effects on 5-HT neurons in the rat dorsal raphe nucleus. Neuroscience 2008; 153: 851-859.
36. GALINDO-CHARLES L, HERNANDES-LOPEZ S, GALARRAGA E, TAPIA D, BARGAS J, GARDUÑO, J, FRÍAS-DOMINGUEZ C, DRUCKER-COLIN R, MIHAILESCU S. Serotonergic dorsal raphe neurons possess functional postsynaptic nicotinic receptors. Synapse 2008; 62: 601-615.
37. BENWELL MEM, BALFOUR DJK, LUCCHI HM. The influence of tetradotoxin and calcium on the stimulation of mesolimbic dopamine activity evoked by systemic nicotine. Psychopharmacology (Berl) 1993; 112: 467-471.
38. BITNER RS, NIKKEL AL, CURZON P, DONNELLY-ROBERTS DL, PUTTFARCKEN PS, NAMOVIC M, JACOBS IC, MEYER MD, DECKER MW. Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat. Brain Res 2000; 871: 66-74.
39. LI X, RAINNIE DG, MCCARLEY RW, GREENE RW. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci 1998; 18: 1904-1912.
40. MIHAILESCU S, GUZMAN-MARIN R, DOMINGUEZ MC, DRUCKER-COLIN R. Mechanisms of nicotine actions on dorsal raphe serotoninergic neurons. Eur J Pharmacol 2002; 452: 77-82.
41. GUZMAN-MARIN R, ALAM MN, MIHAILESCU S, SZYMUSIAK R, SZYMUSIAK R, MCGINTY D, DRUCKER-COLIN R. Subcutaneous administration of nicotine changes dorsal raphe serotonergic neurons discharge rate during REM sleep. Brain Res 2001; 888: 321-325.
42. AZMITIA EC, SEGAL M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978; 179: 641-667.
43. PERRY DC, XIAO Y, NGUYEN HN, MUSACHIO JL, VILA-GARCIA MI, KELLAR KJ. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 2002; 82: 468-481.
44. POPIK P, KOZELA E, KRAWCZYK M. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of Imipramine and citalopram. Br J Pharmacol 2003; 139: 1196-1202.
45. VINCLER MA, EISENACH JC. Immunocytochemical localization of the alpha3, alpha4, alpha5, alpha7, beta2, beta3 and beta4 nicotinic acetylcholine receptor subunits in the locus coeruleus of the rat. Brain Res 2003; 974: 25-36.
46. EGAN TM, NORTH RA. Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro. Neuroscience 1986; 19: 565-571
47. LENA C, DE KERCHOVE DE, CORDERO-ERAUSQUIN M, LE NOVÈRE N, DEL MAR ARROYO-JIMENEZ M, CHANGEUX, JP. Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proc Natl Acad Sci USA 1999; 96: 12126-12131.
48. TOUIKI K, RAT P, MOLIMARD R, CHAIT A, BEAUREPAIRE R DE. Harmane inhibits serotonergic dorsal raphe neurons in the rat. Psychopharmacology (Berl) 2005; 182: 562-569.
49. ROLE LW, BERG DK. Nicotinic receptors in the development and modulation of CNS synapse. Neuron 1996; 16: 1077-1085.
50. WONNACOTT S. Presynaptic nicotinic ACH receptors. Trends Neurosci 1997; 20: 92-98.
51. TOTH E, SESHEN H, HASHIM A, VIZI ES, LAJTHA A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem Res 1992; 17: 265-271.
52. KENNY PJ, FILE SE, NEAL MJ. Evidence for complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem 2000; 75: 2409-2414.
53. MA Z, STRECKER RE, MCKENNA JT, THAKKAR MM, MCCARLEY RW, TAO R. Effects on serotonin of (-)nicotine and dimethylphenylpiperazinium in the dorsal raphe and nucleus accumbens of freely behaving rats. Neuroscience 2005; 135: 949-958.
54. MITCHELL SN. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology 1993; 32: 937-949.
55. POPIK P, KRAWCZYK M, KOS T, NALEPA I, KOWALSKA M, WITARSKI T, ANTKIEWICZ-MICHALUK L, VETULANI J. Nicotine produces antidepressant-like actions: behavioral and neurochemical evidence. Eur J Pharmacol 2005; 515: 128-133.
56. DI CHIARA G IMPERATO A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
57. MARSHALL DL, REDFERN PH, WONNACOTT S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 1997; 68: 1511-1519.
58. SMITH KM, MITCELL SN, JOSEPH MH. Effect of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurons in the rat brain. J Neurochem 1991; 57: 1750-1756.
59. HIREMAGALUR B, SABBAN EL. Nicotine elicits changes in expression of adrenal catecholamine biosynthetic enzymes, neuropeptide Y and immediate early genes by injection but not continuous administration. Brain Res Mol Brain Res 1995; 32: 109-115.
60. SEROVA L, DANAILOV E, CHAMAS F, SABBAN EL. Nicotine infusion modulates immobilization stress triggered induction of gene expression of rat catecholamine biosynthetic enzymes. J Pharmacol Exp Ther 1999; 291: 884-894.
61. SWANSON LW. The projections of the ventral tegmental area and adjacent regions : a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 1982; 9: 321-353.
62. BENWELL ME, BALFOUR DJ, ANDERSON JM. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem 1988; 50: 1243-1247.
63. IMPERATO A, MULAS A, DI CHIARA G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986; 132: 337-338.